Cluster 1 - Health (Single stage - 2025)

Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)

Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

Boosting the translation of biotech research into innovative health therapies

Tackling high-burden for patients and under-researched medical conditions

Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)

Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices

Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Leveraging artificial intelligence for pandemic preparedness and response

End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)

Advancing cell secretome-based therapies

Enhancing cell therapies with genomic techniques

Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)

Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)